Genetic polymorphisms in the human growth hormone-1 gene (GH1) and the risk of breast carcinoma

Cancer

Volumn 101, Issue 2, 2004, Pages 251-257

  Ren, Zefang ^a,b   Cai, Qiuyin ^a,b   Shu, Xiao Ou ^a,b   Cai, Hui ^a,b   Cheng, Jia Rong ^c   Wen, Wan Qing ^a,b   Gao, Yu Tang ^c   Zheng, Wei ^a,b,d  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c SHANGHAI CANCER INSTITUTE   (China)

^d Medical Center East   (United States)

Author keywords

Breast carcinoma; Chinese women; GH1 gene polymorphism; Susceptibility

Indexed keywords

DNA; HUMAN GROWTH HORMONE;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER RISK; CHINESE; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN GROWTH HORMONE 1 GENE; HUMAN TISSUE; IN VIVO STUDY; INTRON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION INITIATION;

EID: 3042785734     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20375     Document Type: Article

References (24)

1. Strobl JS, Thomas MJ. Human growth hormone. Pharmacol Rev. 1994;46:1-34.
2. Laban C, Bustin SA, Jenkins PJ. The GH-IGF-I axis and breast cancer. Trends Endocrinol Metab. 2002;14:28-34.
3. Kleinberg DL. Early mammary development: growth hormone and IGF-1. J Mammary Gland Biol Neoplasia. 1997;2:49-57.
4. Callahan P, Abboud L. A new boost for the vertically challenged - FDA panel gives initial nod to use of growth hormones for healthy but short kids. Wall Street Journal. 2003; Jun 11:D1, D7.
5. Shomali ME. The use of anti-aging hormones. Melatonin, growth hormone, testosterone, and dehydroepiandrosterone: consumer enthusiasm for unproven therapies. Md Med J. 1997;46:181-186.
6. Holly JM, Gunnell DJ, Davey Smith G. Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? J Endocrinol. 1999;162:321-330.
7. Cianfarani S, Tedeschi B, Germani D, et al. In vitro effects of growth hormone (GH) and insulin-like growth factor I and II (IGF-I and -II) on chromosome fragility and p53 protein expression in human lymphocytes. Eur J Clin Invest. 1998;28:41-47.
8. Zhang X, Zhu T, Chen Y, Mertani HC, Lee KO, Lobie PE. Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. J Biol Chem. 2003;278:7580-7590.
9. Raccurt M, Lobie PE, Moudilou E, et al. High stromal and epithelial human GH gene expression is associated with proliferative disorders of the mammary gland. J Endocrinol. 2002;175:307-318.
10. Yang XF, Beamer WG, Huynh H, Pollak M. Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation. Cancer Res. 1996;56:1509-1511.
11. Emerman JT, Leahy M, Gout PW, Bruchovsky N. Elevated growth hormone levels in sera from breast cancer patients. Horm Metab Res. 1985;17:421-424.
12. Chen EY, Liao YC, Smith DH, Barrera-Saldana HA, Gelinas RE, Seeburg PH. The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics. 1989;4:479-497.
13. Horan M, Millar DS, Hedderich J, et al. Human growth hormone 1 (GH1) gene expression: complex haplotype-dependent influence of polymorphic variation in the proximal promoter and locus control region. Hum Mutat. 2003;21:408-423.
14. Giordano M, Marchetti C, Chiorboli E, Bona G, Momigliano Richiardi P. Evidence for gene conversion in the generation of extensive polymorphism in the promoter of the growth hormone gene. Hum Genet. 1997;100:249-255.
15. Hasegawa Y, Fujii K, Yamada M, et al. Identification of novel human GH-1 gene polymorphisms that are associated with growth hormone secretion and height. J Clin Endocrinol Metab. 2000;85:1290-1295.
16. Le Marchand L, Donlon T, Seifried A, Kaaks R, Rinaldi S, Wilkens LR. Association of a common polymorphism in the human GH1 gene with colorectal neoplasia. J Natl Cancer Inst. 2002;94:454-460.
17. Gao YT, Shu XO, Dai Q, et al. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer. 2000;87:295-300.
18. Millar DS, Lewis MD, Horan M, et al. Novel mutations of the growth hormone 1 (GH1) gene disclosed by modulation of the clinical selection criteria for individuals with short stature. Hum Mutat. 2003;21:424-440.
19. Hosmer DW, Lemeshow S. Applied logistic regression (2nd edition). New York: John Wiley & Sons, 2000.
20. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol. 1995;12:921-927.
21. Maison P, Balkau B, Simon D, Chanson P, Rosselin G, Eschwege E. Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective study. BMJ. 1998;316:1132-1133.
22. Swerdlow J, Higgins CD, Adlard P, Preece MA. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet. 2002;360:273-277.
23. Shim M, Cohen P. IGFs and human cancer: implications regarding the risk of growth hormone therapy. Horm Res. 1999;51 Suppl 3:42-51.
24. Ketelslegers JM, Maiter D, Maes M, Underwood LE, Thissen JP. Nutritional regulation of the growth hormone and insulin-like growth factor-binding proteins. Horm Res. 1996;45:252-257.